Starling Oncology, Inc.
No SEC Form 4 filings for $STLN in the last 30 days.
See all $STLN insider activity →Starling Oncology, Inc. (STLN) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 2 ex10x1.htm CREDIT AGREEMENT Exhibit 10.1 CREDIT AGREEMENT among STARLING ONCOLOGY MANAGEMENT, LIMITED LIABILITY COMPANY f/k/a TOI MANAGEMENT, LLC and such other Persons joined hereto as a Borrower from time to time, as Borrowers, with GEMINO HEALTHCARE FINANCE, LLC d/b/
Chernett Jorey purchased 18,000 shares of Oncology Institute, Inc. (DFPH) at $5.27 on 2026-07-21.
Over the past 7 days, alphai's AI scored 1 news story mentioning STLN (Starling Oncology, Inc.). Coverage has been balanced: 0 bullish, 1 neutral, and 0 bearish.
Recent STLN coverage spans corporate actions and insider activity.
The financing provides liquidity for operations but adds debt; stock may react to terms and covenant structure.
Chernett Jorey purchased 18,000 shares of Oncology Institute, Inc. (DFPH) at $5.27 on 2026-07-21.
alphai scores every news story that mentions STLN with an AI model for sentiment and relevance, and aggregates insider trades from Starling Oncology, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Starling Oncology, Inc. (STLN) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 2 ex10x1.htm CREDIT AGREEMENT Exhibit 10.1 CREDIT AGREEMENT among STARLING ONCOLOGY MANAGEMENT, LIMITED LIABILITY COMPANY f/k/a TOI MANAGEMENT, LLC and such other Persons joined hereto as a Borrower from time to time, as Borrowers, with GEMINO HEALTHCARE FINANCE, LLC d/b/
2 min readChernett Jorey purchased 18,000 shares of Oncology Institute, Inc. (DFPH) at $5.27 on 2026-07-21.
1 min read